Medmira Capital Ltd. - Jul 19, 2021 Form 3 Insider Report for HCW Biologics Inc. (HCWB)

Role
10%+ Owner
Signature
/s/ Hing C. Wong, as Attorney-in-Fact.
Stock symbol
HCWB
Transactions as of
Jul 19, 2021
Transactions value $
$0
Form type
3
Date filed
7/19/2021, 05:04 PM
Next filing
Jul 23, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCWB Series B Redeemable Preferred Stock Jul 19, 2021 Common Stock 2.86M Direct F1
holding HCWB Series C Redeemable Preferred Stock Jul 19, 2021 Common Stock 731K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series B Redeemable Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.
F2 The Series C Redeemable Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.

Remarks:

Exhibit 24.1: Power of Attorney